Dr. Matthew Taylor, MD
Claim this profileProvidence Portland Medical Center
Studies Melanoma
Studies Non-Small Cell Lung Cancer
20 reported clinical trials
36 drugs studied
Area of expertise
1Melanoma
Stage IV
Stage III
BRAF positive
2Non-Small Cell Lung Cancer
Stage IV
PD-L1 positive
Stage III
Affiliated Hospitals
Clinical Trials Matthew Taylor, MD is currently running
EP0031
for Cancer
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies (NSCLC)
Recruiting1 award Phase 1 & 2
GB1211 + Pembrolizumab
for Melanoma and Head & Neck Cancer
The purpose of this study is to determine the objective response of GB1211 and pembrolizumab versus pembrolizumab and placebo in patients with advance metastatic melanoma or head and neck squamous cell carcinoma.
Recruiting0 awards Phase 211 criteria
More about Matthew Taylor, MD
Clinical Trial Related5 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Matthew Taylor, MD has experience with
- Pembrolizumab
- Nivolumab
- Cabozantinib
- Cemiplimab
- Placebo
- Sham Device
Breakdown of trials Matthew Taylor, MD has run
Melanoma
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Taylor, MD specialize in?
Matthew Taylor, MD focuses on Melanoma and Non-Small Cell Lung Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Matthew Taylor, MD currently recruiting for clinical trials?
Yes, Matthew Taylor, MD is currently recruiting for 6 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Matthew Taylor, MD has studied deeply?
Yes, Matthew Taylor, MD has studied treatments such as Pembrolizumab, Nivolumab, Cabozantinib.
What is the best way to schedule an appointment with Matthew Taylor, MD?
Apply for one of the trials that Matthew Taylor, MD is conducting.
What is the office address of Matthew Taylor, MD?
The office of Matthew Taylor, MD is located at: Providence Portland Medical Center, Portland, Oregon 97213 United States. This is the address for their practice at the Providence Portland Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.